<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Knowledge of the molecular mechanisms that underlie neuron <z:hpo ids='HP_0011420'>death</z:hpo> after <z:hpo ids='HP_0001297'>stroke</z:hpo> is important to allow the development of effective neuroprotective strategies </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we investigated the contribution of <z:hpo ids='HP_0011420'>death</z:hpo> receptor signaling pathways to neuronal <z:hpo ids='HP_0011420'>death</z:hpo> after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> using in vitro and in vivo models of ischemic injury and transgenic mice that are deficient in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor receptor I (TNFRI KO) or show neuron-specific overexpression of the long isoform of cellular Fas-associated <z:hpo ids='HP_0011420'>death</z:hpo> domain-like interleukin-1-beta-converting enzyme-inhibitory protein (FLIP(L)) </plain></SENT>
<SENT sid="2" pm="."><plain>Caspase 8 was activated in <z:e sem="disease" ids="C0221505" disease_type="Disease or Syndrome" abbrv="">brain lesions</z:e> after permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (pMCAO) and in cortical neurons subjected to <z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation (GD) and was necessary for GD-induced neuron <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Thus, neurons treated with zIETD-FMK <z:chebi fb="7" ids="16670">peptide</z:chebi> or overexpressing a dominant-negative caspase 8 mutant were fully protected against GD-induced <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The presence of the neuroprotective TNFRI was necessary for selectively sustaining p50/p65NF-kappaB activity and the expression of the p43 cleavage form of FLIP(L), FLIP(p43), an endogenous inhibitor of caspase 8, in pMCAO lesions and GD-treated neurons </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, TNF pretreatment further upregulated p50/p65NF-kappaB activity and FLIP(p43) expression in neurons after GD </plain></SENT>
<SENT sid="6" pm="."><plain>The knock-down of FLIP in <z:mp ids='MP_0002169'>wild-type</z:mp> (WT) neurons using a short hairpin <z:chebi fb="40" ids="33697">RNA</z:chebi> revealed that FLIP(L) is essential for TNF/TNFRI-mediated neuroprotection after GD </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, the overexpression of FLIP(L) was sufficient to rescue TNFRI KO neurons from GD-induced <z:hpo ids='HP_0011420'>death</z:hpo> and to enhance TNF neuroprotection in WT neurons, and neuron-specific expression of FLIP(L) in transgenic mice significantly reduced lesion volume after pMCAO </plain></SENT>
<SENT sid="8" pm="."><plain>Our results identify a novel role for the TNFRI-NF-kappaB-FLIP(L) pathway in neuroprotection after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and identify potential new targets for <z:hpo ids='HP_0001297'>stroke</z:hpo> therapy </plain></SENT>
</text></document>